Biofrontera Kicks Off US Clinical Study Program for Ameluz®

Go back to Biofrontera Kicks Off US Clinical Study Program for Ameluz®
(NASDAQ: BFRI) Delayed: 0.82 -0.03 (3.53%)
Previous Close $0.85    52 Week High $ 
Open $0.88    52 Week Low $ 
Day High $0.92    P/E N/A 
Day Low $0.82    EPS $ 
Volume 203,728